Clinical Trial: FES Cycling With BFR in the Spinal Cord Injury Population

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588503) titled 'FES Cycling With BFR in the Spinal Cord Injury Population' on April 14.

Brief Summary: Cardiometabolic Disease (CMD) is the silent killer within the spinal cord injury/disease (SCI/D) population. Many SCI/D patients' initial CMD presentation is with a heart attack, stroke, or sudden cardiac death, highlighting the need for interventions to reduce CMD risk. CMD contributes to 46% of deaths, with 30-50% of the SCI/D population living with undiagnosed CMD. Treating CMD risk is more challenging in the SCI/D population due to prolonged inactivity, inability to exercise, and excessive caloric intake to expenditure ratio. Identifying access...